4.7 Review

Benefits of probiotic use on COVID-19: A systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an in vitro cytokine response assay

Yasunari Kageyama et al.

Summary: Intestinal dysbiosis is associated with COVID-19, and this study demonstrates that Lactobacillus plantarum can enhance immune response and reduce IL-6 levels, suggesting its potential as a probiotic for COVID-19.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)

Article Gastroenterology & Hepatology

Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial

Pedro Gutierrez-Castrellon et al.

Summary: This study suggests that probiotic supplementation can improve lung homeostasis by interacting with the host's immune system, thereby reducing symptoms and severity of COVID-19 infection.

GUT MICROBES (2022)

Article Infectious Diseases

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader et al.

Summary: A study conducted in COVID-19 patients admitted to hospital and requiring oxygen support found that remdesivir did not show significant clinical benefits compared to standard care alone.

LANCET INFECTIOUS DISEASES (2022)

Review Virology

Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review

Santenna Chenchula et al.

Summary: This article discusses the importance and durability of COVID-19 vaccine boosters in the context of the COVID-19 Omicron variant. A systematic review of 27 published studies has been conducted to evaluate the effectiveness of COVID-19 vaccine boosters against the Omicron variant.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Virology

Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials

Ahmed M. Kamel et al.

Summary: The meta-analysis of 7 randomized controlled trials with 8822 patients found that the use of Azithromycin (AZM) in Covid-19 patients did not show significant efficacy or adverse events. Therefore, the routine use of AZM in Covid-19 patients is not recommended.

REVIEWS IN MEDICAL VIROLOGY (2022)

Review Integrative & Complementary Medicine

Effect of infant formula supplemented with prebiotics and probiotics on incidence of respiratory tract infections: A systematic review and meta-analysis of randomized clinical trials

Kamil Rashidi et al.

Summary: This meta-analysis of 15 RCTs found that the consumption of PRO-formula significantly reduces the risk of RTIs in infants, unaffected by the duration of follow-ups. It provides a potential approach for preventing respiratory tract infections in infants.

COMPLEMENTARY THERAPIES IN MEDICINE (2021)

Article Nutrition & Dietetics

Fewer Community-Acquired Colds with Daily Consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A Randomized, Placebo-Controlled Clinical Trial

Irini Lazou Ahren et al.

Summary: The study confirmed the effectiveness of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2 in reducing the incidence of multiple colds in adults. Although no reduction in symptom severity was observed, the probiotics showed a significant decrease in the number of colds experienced, the incidence of recurring colds, and the use of analgesics. Additionally, changes in IFN-gamma levels differed between the probiotic and placebo groups.

JOURNAL OF NUTRITION (2021)

Review Medicine, General & Internal

Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis

J. Deng et al.

Summary: This systematic review and meta-analysis evaluated the efficacy and safety of ivermectin for treating COVID-19 based on peer-reviewed randomized controlled trials and observational studies. The results showed that ivermectin was not associated with significant reductions in time to viral clearance, duration of hospitalization, mortality, or incidence of mechanical ventilation. These findings suggest that ivermectin may not be effective in managing COVID-19.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

Article Food Science & Technology

Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic

Jielun Hu et al.

Summary: The gut microbiome is disrupted in SARS-CoV-2 infections and linked to disease severity, with potential for probiotics and dietary interventions to improve immune response and reduce susceptibility to COVID-19. Studies are ongoing to explore the role of probiotics in protecting against SARS-CoV-2 in different populations, highlighting the potential of microbial therapeutics in preventing and treating COVID-19.

TRENDS IN FOOD SCIENCE & TECHNOLOGY (2021)

Article Microbiology

Effects of a Lactobacilli Probiotic on Reducing Duration of URTI and Fever, and Use of URTI-Associated Medicine: A Re-Analysis of a Randomized, Placebo-Controlled Study

Tatiana Altadill et al.

Summary: The study re-analyzed the effects of Lactoplantibacillus plantarum DR7 probiotic on URTI symptoms and found a significant reduction in the duration of URTI and fever. The recent history of URTI appeared to modulate the efficacy of the probiotic. Additionally, the probiotic group showed a significantly lower average number of months with reported use of URTI-related medication compared to the placebo group.

MICROORGANISMS (2021)

Review Nutrition & Dietetics

Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies

Hai Yun Shi et al.

Summary: Probiotics have shown to have a positive impact on the prevention and treatment of viral respiratory tract infections by modulating gut microbiota to enhance host immunity, decrease viral load, and alleviate symptoms. Further research is needed on next generation probiotics specific to different viral types for the prevention and treatment of emerging viral RTIs.

EUROPEAN JOURNAL OF NUTRITION (2021)

Article Health Care Sciences & Services

The efficacy of probiotics in patients with severe COVID-19

Huaqi Wang et al.

Summary: The study found that the incidence of diarrhea in severe and critical COVID-19 patients was significantly higher than in patients with mild and moderate COVID-19. Treatment with probiotics can significantly shorten the duration of diarrhea and help reduce inflammation markers.

ANNALS OF PALLIATIVE MEDICINE (2021)

Review Nutrition & Dietetics

The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment

Shahrzad Mirashrafi et al.

Summary: This study investigated the potential impact of probiotics on viral diseases, finding that the generation of pro-inflammatory interleukins and type I interferon production seemed to be the main antiviral effects of probiotics. The beneficial effects of probiotics and fermented foods on viral diseases were also highlighted.

CLINICAL NUTRITION ESPEN (2021)

Review Immunology

Meta-Analysis: Randomized Trials of Lactobacillus plantarum on Immune Regulation Over the Last Decades

Wei Zhao et al.

Summary: Meta-analysis results suggest that L. plantarum can promote host immunity by regulating pro-inflammatory and anti-inflammatory cytokines.

FRONTIERS IN IMMUNOLOGY (2021)

Article

Pravila PRISMA 2020.

Matthew J. Page et al.

Medicina Fluminensis (2021)

Article Immunology

The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients

Qiang Li et al.

Summary: Research indicates that probiotics could be an effective treatment strategy for severe COVID-19 patients, reducing the incidence of secondary infections and modulating immunity.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Pathology

Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review

Stefania Caramaschi et al.

Summary: Pathological findings from autopsy and biopsy studies of COVID-19 patients reveal main features of diffuse alveolar damage, thromboembolism, and nonspecific shock injury in multiple organs. Additionally, it suggests a unifying pathogenic mechanism for COVID-19 as ARDS with inflammatory response, cytokine release, fever, inflammation, and generalized endothelial disturbance.

MODERN PATHOLOGY (2021)

Article Nutrition & Dietetics

Oxygen Sparing Effect of Bacteriotherapy in COVID-19

Giancarlo Ceccarelli et al.

Summary: The probiotic formulation SLAB51 can reduce oxygen consumption and maintain blood oxygen levels in severe COVID-19 patients, potentially by reducing nitric oxide synthesis in the intestine.

NUTRIENTS (2021)

Article Biotechnology & Applied Microbiology

Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study

Qiang Wang et al.

Summary: The use of oropharyngeal probiotics significantly reduced the incidence of respiratory tract infections for COVID-19 healthcare workers, while also decreasing the duration of illness and time off work.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Article Immunology

Oral booster probiotic bifidobacteria in SARS-COV-2 patients

Huseyin S. Bozkurt et al.

Summary: Oral administration of booster-single strain probiotic bifidobacteria might be an effective treatment strategy for reducing mortality and length of stay in hospital for moderate/severe SARS-CoV-2 inpatients.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)

Article Gastroenterology & Hepatology

Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19

Lina Zhang et al.

Summary: The study found that the use of probiotics was associated with improved clinical outcomes in patients with COVID-19, leading to shorter time to clinical improvement, reduced duration of fever, viral shedding, and hospital stay. However, further research is needed to validate the effect of probiotics in combating the COVID-19 pandemic.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Article Medicine, General & Internal

Efficiency of application of sorbed probiotics in complex therapy of pneumonia caused by SARS-CoV-2. Part 1. Heating clinical displays period

Elena R. Meskina et al.

Summary: The use of sorbed B. bifidum 1 (5x10(8) KOE) improved the well-being of patients without risk factors with moderate SARS-CoV-2 pneumonia and reduced the duration of diarrheal syndrome in a short time.

TERAPEVTICHESKII ARKHIV (2021)

Article Plant Sciences

Effect of fermented milk on upper respiratory tract infection in adults who lived in the haze area of Northern China: a randomized clinical trial

Hong Zhang et al.

Summary: The study demonstrated that Qingrun yogurt significantly reduced the incidence of common cold and influenza-like illness, as well as shortened the duration and reduced the severity of URTI. Furthermore, levels of interferon-gamma and secretory immunoglobulin A significantly increased in the Qingrun group post-intervention compared to the control group.

PHARMACEUTICAL BIOLOGY (2021)

Review Virology

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Yu Chen et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Review Infectious Diseases

The SARS-CoV-2 outbreak: What we know

Di Wu et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Probiotics for treating acute infectious diarrhoea

Shelui Collinson et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Review Biochemistry & Molecular Biology

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat

Jun Zheng

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Psychiatry

How to perform a meta-analysis with R: a practical tutorial

Sara Balduzzi et al.

EVIDENCE-BASED MENTAL HEALTH (2019)

Article Geriatrics & Gerontology

Probiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial

Biao Wang et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)

Article Biotechnology & Applied Microbiology

Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate

Hong Zhang et al.

SYNTHETIC AND SYSTEMS BIOTECHNOLOGY (2018)

Review Medicine, General & Internal

Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis

Lynne V. McFarland et al.

FRONTIERS IN MEDICINE (2018)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Medicine, General & Internal

Rayyan-a web and mobile app for systematic reviews

Mourad Ouzzani et al.

SYSTEMATIC REVIEWS (2016)

Article Infectious Diseases

Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections

M. Santagati et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)

Review Endocrinology & Metabolism

Probiotic Mechanisms of Action

Miriam Bermudez-Brito et al.

ANNALS OF NUTRITION AND METABOLISM (2012)

Article Health Care Sciences & Services

Meta-analyses of small numbers of trials often agree with longer-term results

Peter Herbison et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)